{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T05:41:11Z","timestamp":1792561271193,"version":"4.5.0"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T00:00:00Z","timestamp":1792540800000},"content-version":"vor","delay-in-days":86,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Epigenet"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Breast cancer develops within a metabolically heterogeneous tumor microenvironment characterized by regional hypoxia, glycolytic activation, lactate accumulation, extracellular acidification, and impaired antitumor immunity. Lactate is now recognized not only as a metabolic end product, but also as a transported substrate, a receptor ligand, and a potential source of lysine lactylation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main body<\/jats:title>\n                    <jats:p>In this Review, we summarize current evidence on lactate production, MCT1\/MCT4-dependent trafficking, GPR81\/HCAR1-mediated sensing, immune remodeling, and metabolic\u2013epigenetic regulation in breast cancer. We organize these effects into three interconnected layers. First, extracellular acidification, nutrient competition, and redox stress produce rapid and potentially reversible suppression of CD8\u207a T cells, natural killer cells, and dendritic cells. Second, sustained lactate-rich conditions alter the relative fitness of immune and stromal populations, weakening cytotoxic effectors while supporting regulatory T cells, tumor-associated macrophages, suppressive myeloid populations, and stromal immune exclusion. Third, histone and non-histone lactylation, together with RNA-level and chromatin regulatory mechanisms, may contribute to more durable state fixation. We distinguish direct breast cancer evidence from mechanisms established in other cancers and from transcriptome-based lactylation-associated signatures. We also discuss methodological limitations, subtype-specific evidence, and therapeutic strategies targeting lactate production, transport, sensing, and downstream epigenetic regulation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Short conclusion<\/jats:title>\n                    <jats:p>Lactate-driven metabolic and epigenetic regulation provides a useful framework for understanding immune evasion and therapeutic resistance in breast cancer. However, direct mechanistic evidence remains concentrated in triple-negative breast cancer and tumor-intrinsic phenotypes. Lactylation should therefore be considered a candidate mechanism of durable state fixation rather than a universal explanation for lactate-associated effects. Future studies integrating direct lactylation measurements, spatial multi-omics, functional perturbation, and patient-derived models will be required to define clinically actionable lactate-dependent states.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13148-026-02216-8","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T02:33:23Z","timestamp":1785119603000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Lactate-driven metabolic\u2013epigenetic reprogramming in breast cancer: immune evasion and therapeutic resistance"],"prefix":"10.1186","volume":"18","author":[{"given":"Lei","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanqin","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyan","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,27]]},"reference":[{"issue":"10074","key":"2216_CR1","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1016\/S0140-6736(16)31891-8","volume":"389","author":"N Harbeck","year":"2017","unstructured":"Harbeck N, Gnant M. Breast cancer. Lancet. 2017;389(10074):1134\u201350.","journal-title":"Lancet"},{"issue":"2","key":"2216_CR2","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s10555-025-10264-4","volume":"44","author":"Y Qiao","year":"2025","unstructured":"Qiao Y, Liu Y, Ran R, Zhou Y, Gong J, Liu L, et al. Lactate metabolism and lactylation in breast cancer: mechanisms and implications. Cancer Metastasis Rev. 2025;44(2):48.","journal-title":"Cancer Metastasis Rev"},{"key":"2216_CR3","doi-asserted-by":"publisher","first-page":"1381970","DOI":"10.3389\/fimmu.2024.1381970","volume":"15","author":"J Zou","year":"2024","unstructured":"Zou J, Mai C, Lin Z, Zhou J, Lai G. Targeting metabolism of breast cancer and its implications in T cell immunotherapy. Front Immunol. 2024;15:1381970.","journal-title":"Front Immunol"},{"issue":"1","key":"2216_CR4","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","volume":"23","author":"NN Pavlova","year":"2016","unstructured":"Pavlova NN, Thompson CB. The Emerging Hallmarks of Cancer Metabolism. Cell Metab. 2016;23(1):27\u201347.","journal-title":"Cell Metab"},{"issue":"5","key":"2216_CR5","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.cmet.2016.08.011","volume":"24","author":"A Brand","year":"2016","unstructured":"Brand A, Singer K, Koehl GE, Kolitzus M, Schoenhammer G, Thiel A, et al. LDHA-Associated Lactic Acid Production Blunts Tumor Immunosurveillance by T and NK Cells. Cell Metab. 2016;24(5):657\u201371.","journal-title":"Cell Metab"},{"issue":"7","key":"2216_CR6","first-page":"789","volume":"22","author":"L Huang","year":"2025","unstructured":"Huang L, Chen X, Yan M, Xiang Z, Wu J. Lactate and lactylation in breast cancer: current understanding and therapeutic opportunities. Cancer Biol Med. 2025;22(7):789\u2013805.","journal-title":"Cancer Biol Med"},{"issue":"21","key":"2216_CR7","doi-asserted-by":"publisher","first-page":"8363","DOI":"10.3390\/ijms21218363","volume":"21","author":"JX Wang","year":"2020","unstructured":"Wang JX, Choi SYC, Niu X, Kang N, Xue H, Killam J, et al. Lactic acid and an acidic tumor microenvironment suppress anticancer immunity. Int J Mol Sci. 2020;21(21):8363.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"2216_CR8","doi-asserted-by":"publisher","first-page":"2746","DOI":"10.1158\/0008-5472.CAN-11-1272","volume":"72","author":"A Calcinotto","year":"2012","unstructured":"Calcinotto A, Filipazzi P, Grioni M, Iero M, De Milito A, Ricupito A, et al. Modulation of microenvironment acidity reverses anergy in human and murine tumor-infiltrating T lymphocytes. Cancer Res. 2012;72(11):2746\u201356.","journal-title":"Cancer Res"},{"key":"2216_CR9","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3389\/fonc.2018.00081","volume":"8","author":"A Morrot","year":"2018","unstructured":"Morrot A, da Fonseca LM, Salustiano EJ, Gentile LB, Conde L, Filardy AA, et al. Metabolic Symbiosis and Immunomodulation: How Tumor Cell-Derived Lactate May Disturb Innate and Adaptive Immune Responses. Front Oncol. 2018;8:81.","journal-title":"Front Oncol"},{"issue":"4","key":"2216_CR10","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.cmet.2018.03.008","volume":"27","author":"GA Brooks","year":"2018","unstructured":"Brooks GA. The Science and Translation of Lactate Shuttle Theory. Cell Metab. 2018;27(4):757\u201385.","journal-title":"Cell Metab"},{"issue":"16","key":"2216_CR11","doi-asserted-by":"publisher","first-page":"3292","DOI":"10.1038\/s41388-020-1216-5","volume":"39","author":"TP Brown","year":"2020","unstructured":"Brown TP, Bhattacharjee P, Ramachandran S, Sivaprakasam S, Ristic B, Sikder MOF, et al. The lactate receptor GPR81 promotes breast cancer growth via a paracrine mechanism involving antigen-presenting cells in the tumor microenvironment. Oncogene. 2020;39(16):3292\u2013304.","journal-title":"Oncogene"},{"issue":"1","key":"2216_CR12","doi-asserted-by":"publisher","first-page":"6261","DOI":"10.1038\/s41598-022-10143-w","volume":"12","author":"S Ishihara","year":"2022","unstructured":"Ishihara S, Hata K, Hirose K, Okui T, Toyosawa S, Uzawa N, et al. The lactate sensor GPR81 regulates glycolysis and tumor growth of breast cancer. Sci Rep. 2022;12(1):6261.","journal-title":"Sci Rep"},{"issue":"10","key":"2216_CR13","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.tem.2022.07.004","volume":"33","author":"M Certo","year":"2022","unstructured":"Certo M, Llibre A, Lee W, Mauro C. Understanding lactate sensing and signalling. Trends Endocrinol Metab. 2022;33(10):722\u201335.","journal-title":"Trends Endocrinol Metab"},{"issue":"7779","key":"2216_CR14","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41586-019-1678-1","volume":"574","author":"D Zhang","year":"2019","unstructured":"Zhang D, Tang Z, Huang H, Zhou G, Cui C, Weng Y, et al. Metabolic regulation of gene expression by histone lactylation. Nature. 2019;574(7779):575\u201380.","journal-title":"Nature"},{"issue":"7","key":"2216_CR15","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/s41592-022-01536-w","volume":"19","author":"X Wu","year":"2022","unstructured":"Wu X, Tao WA. Uncovering ubiquitous protein lactylation. Nat Methods. 2022;19(7):793\u20134.","journal-title":"Nat Methods"},{"issue":"11","key":"2216_CR16","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1016\/j.ccell.2024.09.006","volume":"42","author":"H Li","year":"2024","unstructured":"Li H, Sun L, Gao P, Hu H. Lactylation in cancer: Current understanding and challenges. Cancer Cell. 2024;42(11):1803\u20137.","journal-title":"Cancer Cell"},{"issue":"3","key":"2216_CR17","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.immuni.2025.02.008","volume":"58","author":"A Llibre","year":"2025","unstructured":"Llibre A, Kucuk S, Gope A, Certo M, Mauro C, Lactate. A key regulator of the immune response. Immunity. 2025;58(3):535\u201354.","journal-title":"Immunity"},{"issue":"1","key":"2216_CR18","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1186\/s12885-023-11631-6","volume":"23","author":"K Lundo","year":"2023","unstructured":"Lundo K, Dmytriyeva O, Spohr L, Goncalves-Alves E, Yao J, Blasco LP, et al. Lactate receptor GPR81 drives breast cancer growth and invasiveness through regulation of ECM properties and Notch ligand DLL4. BMC Cancer. 2023;23(1):1136.","journal-title":"BMC Cancer"},{"issue":"7851","key":"2216_CR19","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/s41586-020-03045-2","volume":"591","author":"MJ Watson","year":"2021","unstructured":"Watson MJ, Vignali PDA, Mullett SJ, Overacre-Delgoffe AE, Peralta RM, Grebinoski S, et al. Metabolic support of tumour-infiltrating regulatory T cells by lactic acid. Nature. 2021;591(7851):645\u201351.","journal-title":"Nature"},{"issue":"4","key":"2216_CR20","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1080\/15384101.2018.1444305","volume":"17","author":"X Mu","year":"2018","unstructured":"Mu X, Shi W, Xu Y, Xu C, Zhao T, Geng B, et al. Tumor-derived lactate induces M2 macrophage polarization via the activation of the ERK\/STAT3 signaling pathway in breast cancer. Cell Cycle. 2018;17(4):428\u201338.","journal-title":"Cell Cycle"},{"issue":"95","key":"2216_CR21","doi-asserted-by":"publisher","first-page":"eadi4191","DOI":"10.1126\/sciimmunol.adi4191","volume":"9","author":"MP Plebanek","year":"2024","unstructured":"Plebanek MP, Xue Y, Nguyen YV, DeVito NC, Wang X, Holtzhausen A, et al. A lactate-SREBP2 signaling axis drives tolerogenic dendritic cell maturation and promotes cancer progression. Sci Immunol. 2024;9(95):eadi4191.","journal-title":"Sci Immunol"},{"issue":"1","key":"2216_CR22","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1186\/s12935-024-03520-0","volume":"24","author":"F Cappellesso","year":"2024","unstructured":"Cappellesso F, Mazzone M, Virga F. Acid affairs in anti-tumour immunity. Cancer Cell Int. 2024;24(1):354.","journal-title":"Cancer Cell Int"},{"key":"2216_CR23","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3390\/cells13221924","volume":"13","author":"MA Rahman","year":"2024","unstructured":"Rahman MA, Yadab MK, Ali MM. Emerging Role of Extracellular pH in Tumor Microenvironment as a Therapeutic Target for Cancer Immunotherapy. Cells. 2024;13:22.","journal-title":"Cells"},{"key":"2216_CR24","doi-asserted-by":"publisher","first-page":"231","DOI":"10.3389\/fonc.2020.00231","volume":"10","author":"F Baltazar","year":"2020","unstructured":"Baltazar F, Afonso J, Costa M, Granja S. Lactate Beyond a Waste Metabolite: Metabolic Affairs and Signaling in Malignancy. Front Oncol. 2020;10:231.","journal-title":"Front Oncol"},{"issue":"9","key":"2216_CR25","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1002\/iub.93","volume":"60","author":"GL Semenza","year":"2008","unstructured":"Semenza GL. Hypoxia-inducible factor 1 and cancer pathogenesis. IUBMB Life. 2008;60(9):591\u20137.","journal-title":"IUBMB Life"},{"issue":"2","key":"2216_CR26","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.tibs.2018.10.011","volume":"44","author":"L Ippolito","year":"2019","unstructured":"Ippolito L, Morandi A, Giannoni E, Chiarugi P. Lactate: A Metabolic Driver in the Tumour Landscape. Trends Biochem Sci. 2019;44(2):153\u201366.","journal-title":"Trends Biochem Sci"},{"issue":"5","key":"2216_CR27","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1152\/physiolgenomics.00177.2010","volume":"43","author":"R Hussien","year":"2011","unstructured":"Hussien R, Brooks GA. Mitochondrial and plasma membrane lactate transporter and lactate dehydrogenase isoform expression in breast cancer cell lines. Physiol Genomics. 2011;43(5):255\u201364.","journal-title":"Physiol Genomics"},{"issue":"7","key":"2216_CR28","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1016\/j.celrep.2016.01.057","volume":"14","author":"CS Hong","year":"2016","unstructured":"Hong CS, Graham NA, Gu W, Espindola Camacho C, Mah V, Maresh EL, et al. MCT1 Modulates Cancer Cell Pyruvate Export and Growth of Tumors that Co-express MCT1 and MCT4. Cell Rep. 2016;14(7):1590\u2013601.","journal-title":"Cell Rep"},{"issue":"2","key":"2216_CR29","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1002\/path.4562","volume":"237","author":"F Baenke","year":"2015","unstructured":"Baenke F, Dubuis S, Brault C, Weigelt B, Dankworth B, Griffiths B, et al. Functional screening identifies MCT4 as a key regulator of breast cancer cell metabolism and survival. J Pathol. 2015;237(2):152\u201365.","journal-title":"J Pathol"},{"issue":"2","key":"2216_CR30","doi-asserted-by":"publisher","first-page":"268","DOI":"10.3892\/mmr.2022.12784","volume":"26","author":"L Jin","year":"2022","unstructured":"Jin L, Guo Y, Chen J, Wen Z, Jiang Y, Qian J. Lactate receptor HCAR1 regulates cell growth, metastasis and maintenance of cancer\u2013specific energy metabolism in breast cancer cells. Mol Med Rep. 2022;26(2):268.","journal-title":"Mol Med Rep"},{"issue":"9","key":"2216_CR31","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1002\/mc.23582","volume":"62","author":"S Guo","year":"2023","unstructured":"Guo S, Zhou J, Lou P, Weng L, Ye X, Guo J, et al. Potentiated effects of lactate receptor GPR81 on immune microenvironment in breast cancer. Mol Carcinog. 2023;62(9):1369\u201377.","journal-title":"Mol Carcinog"},{"issue":"1","key":"2216_CR32","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12943-021-01316-8","volume":"20","author":"L Xia","year":"2021","unstructured":"Xia L, Oyang L, Lin J, Tan S, Han Y, Wu N, et al. The cancer metabolic reprogramming and immune response. Mol Cancer. 2021;20(1):28.","journal-title":"Mol Cancer"},{"issue":"6487","key":"2216_CR33","doi-asserted-by":"publisher","first-page":"eaaw5473","DOI":"10.1126\/science.aaw5473","volume":"368","author":"B Faubert","year":"2020","unstructured":"Faubert B, Solmonson A, DeBerardinis RJ. Metabolic reprogramming and cancer progression. Science. 2020;368(6487):eaaw5473.","journal-title":"Science"},{"issue":"12","key":"2216_CR34","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1038\/s41590-024-01999-3","volume":"25","author":"RM Peralta","year":"2024","unstructured":"Peralta RM, Xie B, Lontos K, Nieves-Rosado H, Spahr K, Joshi S, et al. Dysfunction of exhausted T cells is enforced by MCT11-mediated lactate metabolism. Nat Immunol. 2024;25(12):2297\u2013307.","journal-title":"Nat Immunol"},{"issue":"10","key":"2216_CR35","doi-asserted-by":"publisher","first-page":"e007349","DOI":"10.1136\/jitc-2023-007349","volume":"11","author":"N Babl","year":"2023","unstructured":"Babl N, Decking SM, Voll F, Althammer M, Sala-Hojman A, Ferretti R, et al. MCT4 blockade increases the efficacy of immune checkpoint blockade. J Immunother Cancer. 2023;11(10):e007349.","journal-title":"J Immunother Cancer"},{"issue":"3","key":"2216_CR36","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.immuni.2024.01.019","volume":"57","author":"R Ding","year":"2024","unstructured":"Ding R, Yu X, Hu Z, Dong Y, Huang H, Zhang Y, et al. Lactate modulates RNA splicing to promote CTLA-4 expression in tumor-infiltrating regulatory T cells. Immunity. 2024;57(3):528\u201340. e6.","journal-title":"Immunity"},{"issue":"12","key":"2216_CR37","doi-asserted-by":"publisher","first-page":"e010040","DOI":"10.1136\/jitc-2024-010040","volume":"12","author":"Q Xue","year":"2024","unstructured":"Xue Q, Peng W, Zhang S, Wei X, Ye L, Wang Z, et al. Lactylation-driven TNFR2 expression in regulatory T cells promotes the progression of malignant pleural effusion. J Immunother Cancer. 2024;12(12):e010040.","journal-title":"J Immunother Cancer"},{"issue":"2","key":"2216_CR38","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.ccell.2022.01.001","volume":"40","author":"S Kumagai","year":"2022","unstructured":"Kumagai S, Koyama S, Itahashi K, Tanegashima T, Lin YT, Togashi Y, et al. Lactic acid promotes PD-1 expression in regulatory T cells in highly glycolytic tumor microenvironments. Cancer Cell. 2022;40(2):201\u201318. e9.","journal-title":"Cancer Cell"},{"key":"2216_CR39","first-page":"101317","volume":"31","author":"Y Shi","year":"2022","unstructured":"Shi Y, Yasui M, Hara-Chikuma M. AQP9 transports lactate in tumor-associated macrophages to stimulate an M2-like polarization that promotes colon cancer progression. Biochem Biophys Rep. 2022;31:101317.","journal-title":"Biochem Biophys Rep"},{"issue":"46","key":"2216_CR40","doi-asserted-by":"publisher","first-page":"eabi8602","DOI":"10.1126\/sciadv.abi8602","volume":"7","author":"JT Noe","year":"2021","unstructured":"Noe JT, Rendon BE, Geller AE, Conroy LR, Morrissey SM, Young LEA, et al. Lactate supports a metabolic-epigenetic link in macrophage polarization. Sci Adv. 2021;7(46):eabi8602.","journal-title":"Sci Adv"},{"key":"2216_CR41","doi-asserted-by":"publisher","first-page":"123810","DOI":"10.1016\/j.ijbiomac.2023.123810","volume":"237","author":"X Fang","year":"2023","unstructured":"Fang X, Zhao P, Gao S, Liu D, Zhang S, Shan M, et al. Lactate induces tumor-associated macrophage polarization independent of mitochondrial pyruvate carrier-mediated metabolism. Int J Biol Macromol. 2023;237:123810.","journal-title":"Int J Biol Macromol"},{"key":"2216_CR42","doi-asserted-by":"publisher","first-page":"1492050","DOI":"10.3389\/fimmu.2024.1492050","volume":"15","author":"M Jiang","year":"2024","unstructured":"Jiang M, Wang Y, Zhao X, Yu J. From metabolic byproduct to immune modulator: the role of lactate in tumor immune escape. Front Immunol. 2024;15:1492050.","journal-title":"Front Immunol"},{"issue":"2","key":"2216_CR43","doi-asserted-by":"publisher","first-page":"197","DOI":"10.15407\/exp-oncology.2025.02.197","volume":"47","author":"A Pavlova","year":"2025","unstructured":"Pavlova A, Mushii O, Bazas V, Karacharova I, Zadvornyi T, Lukianova N. Tumor-Associated Macrophages: Relationship with Clinical Status of Patients and Molecular Biological Features of Breast Cancer. Exp Oncol. 2025;47(2):197\u2013206.","journal-title":"Exp Oncol"},{"issue":"10","key":"2216_CR44","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1016\/j.cell.2024.04.002","volume":"187","author":"Z Zong","year":"2024","unstructured":"Zong Z, Xie F, Wang S, Wu X, Zhang Z, Yang B, et al. Alanyl-tRNA synthetase, AARS1, is a lactate sensor and lactyltransferase that lactylates p53 and contributes to tumorigenesis. Cell. 2024;187(10):2375\u2013e9233.","journal-title":"Cell"},{"issue":"7","key":"2216_CR45","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/j.molcel.2025.02.011","volume":"85","author":"M Iozzo","year":"2025","unstructured":"Iozzo M, Pardella E, Giannoni E, Chiarugi P. The role of protein lactylation: A kaleidoscopic post-translational modification in cancer. Mol Cell. 2025;85(7):1263\u201379.","journal-title":"Mol Cell"},{"issue":"1","key":"2216_CR46","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s40364-025-00849-0","volume":"13","author":"S Xiao","year":"2025","unstructured":"Xiao S, Zhang S, Sun K, Huang Q, Li Q, Hu C. Lactate and lactylation: molecular insights into histone and non-histone lactylation in tumor progression, tumor immune microenvironment, and therapeutic strategies. Biomark Res. 2025;13(1):134.","journal-title":"Biomark Res"},{"issue":"1","key":"2216_CR47","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13148-024-01682-2","volume":"16","author":"Y Hu","year":"2024","unstructured":"Hu Y, He Z, Li Z, Wang Y, Wu N, Sun H, et al. Lactylation: the novel histone modification influence on gene expression, protein function, and disease. Clin Epigenetics. 2024;16(1):72.","journal-title":"Clin Epigenetics"},{"issue":"2","key":"2216_CR48","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.chembiol.2019.11.005","volume":"27","author":"DO Gaffney","year":"2020","unstructured":"Gaffney DO, Jennings EQ, Anderson CC, Marentette JO, Shi T, Schou Oxvig AM, et al. Non-enzymatic Lysine Lactoylation of Glycolytic Enzymes. Cell Chem Biol. 2020;27(2):206\u201313. e6.","journal-title":"Cell Chem Biol"},{"issue":"1","key":"2216_CR49","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41589-024-01680-8","volume":"21","author":"D Zhang","year":"2025","unstructured":"Zhang D, Gao J, Zhu Z, Mao Q, Xu Z, Singh PK, et al. Lysine L-lactylation is the dominant lactylation isomer induced by glycolysis. Nat Chem Biol. 2025;21(1):91\u20139.","journal-title":"Nat Chem Biol"},{"issue":"1","key":"2216_CR50","doi-asserted-by":"publisher","first-page":"3561","DOI":"10.1038\/s41467-024-47900-6","volume":"15","author":"Z Niu","year":"2024","unstructured":"Niu Z, Chen C, Wang S, Lu C, Wu Z, Wang A, et al. HBO1 catalyzes lysine lactylation and mediates histone H3K9la to regulate gene transcription. Nat Commun. 2024;15(1):3561.","journal-title":"Nat Commun"},{"issue":"8","key":"2216_CR51","doi-asserted-by":"publisher","first-page":"e2314128121","DOI":"10.1073\/pnas.2314128121","volume":"121","author":"B Xie","year":"2024","unstructured":"Xie B, Zhang M, Li J, Cui J, Zhang P, Liu F, et al. KAT8-catalyzed lactylation promotes eEF1A2-mediated protein synthesis and colorectal carcinogenesis. Proc Natl Acad Sci U S A. 2024;121(8):e2314128121.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"2216_CR52","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/s41420-025-02501-0","volume":"11","author":"ZL Zhang","year":"2025","unstructured":"Zhang ZL, Ren ST, Yang WJ, Xu XW, Zhao SM, Fang KF, et al. AARS2-catalyzed lactylation induces follicle development and premature ovarian insufficiency. Cell Death Discov. 2025;11(1):209.","journal-title":"Cell Death Discov"},{"issue":"10","key":"2216_CR53","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1016\/j.scib.2024.11.049","volume":"70","author":"S Wang","year":"2025","unstructured":"Wang S, Lv H, Zhou F. AARS1 and AARS2, the L-lactate sensors and universal lactyltransferases. Sci Bull (Beijing). 2025;70(10):1547\u20139.","journal-title":"Sci Bull (Beijing)"},{"issue":"10","key":"2216_CR54","doi-asserted-by":"publisher","first-page":"110602","DOI":"10.1016\/j.jbc.2025.110602","volume":"301","author":"MB Gonzatti","year":"2025","unstructured":"Gonzatti MB, Hintzen JCJ, Sharma I, Najar MA, Tsusaka T, Marcinkiewicz MM, et al. Class I histone deacetylases catalyze lysine lactylation. J Biol Chem. 2025;301(10):110602.","journal-title":"J Biol Chem"},{"issue":"3","key":"2216_CR55","doi-asserted-by":"publisher","first-page":"eabi6696","DOI":"10.1126\/sciadv.abi6696","volume":"8","author":"C Moreno-Yruela","year":"2022","unstructured":"Moreno-Yruela C, Zhang D, Wei W, Baek M, Liu W, Gao J, et al. Class I histone deacetylases (HDAC1-3) are histone lysine delactylases. Sci Adv. 2022;8(3):eabi6696.","journal-title":"Sci Adv"},{"issue":"10","key":"2216_CR56","doi-asserted-by":"publisher","first-page":"110911","DOI":"10.1016\/j.isci.2024.110911","volume":"27","author":"R Du","year":"2024","unstructured":"Du R, Gao Y, Yan C, Ren X, Qi S, Liu G, et al. Sirtuin 1\/sirtuin 3 are robust lysine delactylases and sirtuin 1-mediated delactylation regulates glycolysis. iScience. 2024;27(10):110911.","journal-title":"iScience"},{"issue":"10","key":"2216_CR57","doi-asserted-by":"publisher","first-page":"5529","DOI":"10.1093\/nar\/gkae183","volume":"52","author":"X Hu","year":"2024","unstructured":"Hu X, Huang X, Yang Y, Sun Y, Zhao Y, Zhang Z, et al. Dux activates metabolism-lactylation-MET network during early iPSC reprogramming with Brg1 as the histone lactylation reader. Nucleic Acids Res. 2024;52(10):5529\u201348.","journal-title":"Nucleic Acids Res"},{"issue":"12","key":"2216_CR58","doi-asserted-by":"publisher","first-page":"2418","DOI":"10.1021\/acschembio.4c00248","volume":"19","author":"R Nunez","year":"2024","unstructured":"Nunez R, Sidlowski PFW, Steen EA, Wynia-Smith SL, Sprague DJ, Keyes RF, et al. The TRIM33 Bromodomain Recognizes Histone Lysine Lactylation. ACS Chem Biol. 2024;19(12):2418\u201328.","journal-title":"ACS Chem Biol"},{"issue":"50","key":"2216_CR59","doi-asserted-by":"publisher","first-page":"e2421496121","DOI":"10.1073\/pnas.2421496121","volume":"121","author":"G Zhai","year":"2024","unstructured":"Zhai G, Niu Z, Jiang Z, Zhao F, Wang S, Chen C, et al. DPF2 reads histone lactylation to drive transcription and tumorigenesis. Proc Natl Acad Sci U S A. 2024;121(50):e2421496121.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2216_CR60","doi-asserted-by":"publisher","first-page":"111468","DOI":"10.1016\/j.cellsig.2024.111468","volume":"124","author":"J Li","year":"2024","unstructured":"Li J, Chen Z, Jin M, Gu X, Wang Y, Huang G, et al. Histone H4K12 lactylation promotes malignancy progression in triple-negative breast cancer through SLFN5 downregulation. Cell Signal. 2024;124:111468.","journal-title":"Cell Signal"},{"key":"2216_CR61","doi-asserted-by":"publisher","first-page":"1328679","DOI":"10.3389\/fendo.2024.1328679","volume":"15","author":"Z Cui","year":"2024","unstructured":"Cui Z, Li Y, Lin Y, Zheng C, Luo L, Hu D, et al. Lactylproteome analysis indicates histone H4K12 lactylation as a novel biomarker in triple-negative breast cancer. Front Endocrinol (Lausanne). 2024;15:1328679.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"2216_CR62","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/s41420-025-02334-x","volume":"11","author":"Y Xu","year":"2025","unstructured":"Xu Y, Meng W, Dai Y, Xu L, Ding N, Zhang J, et al. Anaerobic metabolism promotes breast cancer survival via Histone-3 Lysine-18 lactylation mediating PPARD axis. Cell Death Discov. 2025;11(1):54.","journal-title":"Cell Death Discov"},{"key":"2216_CR63","doi-asserted-by":"publisher","first-page":"101758","DOI":"10.1016\/j.tranon.2023.101758","volume":"37","author":"MR Pandkar","year":"2023","unstructured":"Pandkar MR, Sinha S, Samaiya A, Shukla S. Oncometabolite lactate enhances breast cancer progression by orchestrating histone lactylation-dependent c-Myc expression. Transl Oncol. 2023;37:101758.","journal-title":"Transl Oncol"},{"issue":"6","key":"2216_CR64","doi-asserted-by":"publisher","first-page":"e3002666","DOI":"10.1371\/journal.pbio.3002666","volume":"22","author":"X Hou","year":"2024","unstructured":"Hou X, Ouyang J, Tang L, Wu P, Deng X, Yan Q, et al. KCNK1 promotes proliferation and metastasis of breast cancer cells by activating lactate dehydrogenase A (LDHA) and up-regulating H3K18 lactylation. PLoS Biol. 2024;22(6):e3002666.","journal-title":"PLoS Biol"},{"key":"2216_CR65","doi-asserted-by":"publisher","first-page":"218328","DOI":"10.1016\/j.canlet.2026.218328","volume":"644","author":"Z Zhao","year":"2026","unstructured":"Zhao Z, Jia W, Li Z, Shi S, Zhou J, Ning C, et al. Targeting the SIN1 mediated TTK\/LDHA-H3K18la-GLUT3 axis disrupts metabolic-epigenetic crosstalk and suppresses progression in hyperglycolytic breast cancer. Cancer Lett. 2026;644:218328.","journal-title":"Cancer Lett"},{"key":"2216_CR66","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noag114","author":"S Liu","year":"2026","unstructured":"Liu S, Bai Z, Qiao Y, Ge Y, Qu F, Li M, et al. LDHA-mediated CREB1 lactylation promotes breast cancer brain metastasis by transcriptionally activating cytoskeletal remodeling. Neuro Oncol. 2026. https:\/\/doi.org\/10.1093\/neuonc\/noag114","journal-title":"Neuro Oncol"},{"key":"2216_CR67","doi-asserted-by":"publisher","first-page":"1747043","DOI":"10.3389\/fimmu.2026.1747043","volume":"17","author":"J Chen","year":"2026","unstructured":"Chen J, Hao Y, Feng Y, Dai Y, Shi H, Zhu L. Lactylation-mediated remodelling of the breast cancer microenvironment: single-cell multidimensional analysis and prognostic model construction. Front Immunol. 2026;17:1747043.","journal-title":"Front Immunol"},{"issue":"6","key":"2216_CR68","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.7150\/thno.105947","volume":"15","author":"Z Ma","year":"2025","unstructured":"Ma Z, Yang J, Jia W, Li L, Li Y, Hu J, et al. Histone lactylation-driven B7-H3 expression promotes tumor immune evasion. Theranostics. 2025;15(6):2338\u201359.","journal-title":"Theranostics"},{"issue":"1","key":"2216_CR69","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1080\/07357907.2024.2430283","volume":"43","author":"X Hu","year":"2025","unstructured":"Hu X, Huang Z, Li L. LDHB Mediates Histone Lactylation to Activate PD-L1 and Promote Ovarian Cancer Immune Escape. Cancer Invest. 2025;43(1):70\u20139.","journal-title":"Cancer Invest"},{"issue":"1","key":"2216_CR70","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/s41392-023-01605-2","volume":"8","author":"ZW Huang","year":"2023","unstructured":"Huang ZW, Zhang XN, Zhang L, Liu LL, Zhang JW, Sun YX, et al. STAT5 promotes PD-L1 expression by facilitating histone lactylation to drive immunosuppression in acute myeloid leukemia. Signal Transduct Target Ther. 2023;8(1):391.","journal-title":"Signal Transduct Target Ther"},{"key":"2216_CR71","doi-asserted-by":"publisher","DOI":"10.1172\/JCI187024","author":"K Sun","year":"2025","unstructured":"Sun K, Zhang X, Shi J, Huang J, Wang S, Li X, et al. Elevated protein lactylation promotes immunosuppressive microenvironment and therapeutic resistance in pancreatic ductal adenocarcinoma. J Clin Invest. 2025. https:\/\/doi.org\/10.1172\/JCI187024","journal-title":"J Clin Invest"},{"issue":"9","key":"2216_CR72","doi-asserted-by":"publisher","first-page":"114686","DOI":"10.1016\/j.celrep.2024.114686","volume":"43","author":"R Wang","year":"2024","unstructured":"Wang R, Li C, Cheng Z, Li M, Shi J, Zhang Z, et al. H3K9 lactylation in malignant cells facilitates CD8(+) T cell dysfunction and poor immunotherapy response. Cell Rep. 2024;43(9):114686.","journal-title":"Cell Rep"},{"key":"2216_CR73","doi-asserted-by":"publisher","first-page":"116125","DOI":"10.1016\/j.intimp.2025.116125","volume":"170","author":"Y Cai","year":"2026","unstructured":"Cai Y, Li X, Zhu S, Wu H, Nie J, Huang F. Lactate represses MHC-I antigen presentation via H4K5 lactylation-PRC2 in small cell lung cancer subtype A. Int Immunopharmacol. 2026;170:116125.","journal-title":"Int Immunopharmacol"},{"issue":"3","key":"2216_CR74","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1021\/acs.jproteome.5c00969","volume":"25","author":"L Donnellan","year":"2026","unstructured":"Donnellan L, Young C, Seidel JD, Peake B, Lau D, Deo P, et al. An Investigation into the Differentiation of Lactyllysine and Carboxyethyllysine Peptide Modifications by Liquid Chromatography\/Mass Spectrometry. J Proteome Res. 2026;25(3):1601\u201310.","journal-title":"J Proteome Res"},{"issue":"7","key":"2216_CR75","doi-asserted-by":"publisher","first-page":"101601","DOI":"10.1016\/j.mcpro.2026.101601","volume":"25","author":"J Manessier","year":"2026","unstructured":"Manessier J, Hijazi H, Vizzini L, Brugiere S, Courcon M, Masselon C, et al. Both L-Lactyl and D-Lactyl Enantiomers Modify Histones in Mouse Testis. Mol Cell Proteom. 2026;25(7):101601.","journal-title":"Mol Cell Proteom"},{"issue":"2","key":"2216_CR76","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41573-021-00339-6","volume":"21","author":"ZE Stine","year":"2022","unstructured":"Stine ZE, Schug ZT, Salvino JM, Dang CV. Targeting cancer metabolism in the era of precision oncology. Nat Rev Drug Discov. 2022;21(2):141\u201362.","journal-title":"Nat Rev Drug Discov"},{"issue":"2","key":"2216_CR77","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s00280-012-2045-1","volume":"71","author":"LE Raez","year":"2013","unstructured":"Raez LE, Papadopoulos K, Ricart AD, Chiorean EG, Dipaola RS, Stein MN, et al. A phase I dose-escalation trial of 2-deoxy-D-glucose alone or combined with docetaxel in patients with advanced solid tumors. Cancer Chemother Pharmacol. 2013;71(2):523\u201330.","journal-title":"Cancer Chemother Pharmacol"},{"issue":"8","key":"2216_CR78","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1158\/1078-0432.CCR-22-2263","volume":"29","author":"S Halford","year":"2023","unstructured":"Halford S, Veal GJ, Wedge SR, Payne GS, Bacon CM, Sloan P, et al. A Phase I Dose-escalation Study of AZD3965, an Oral Monocarboxylate Transporter 1 Inhibitor, in Patients with Advanced Cancer. Clin cancer research: official J Am Association Cancer Res. 2023;29(8):1429\u201339.","journal-title":"Clin cancer research: official J Am Association Cancer Res"},{"issue":"6","key":"2216_CR79","doi-asserted-by":"publisher","first-page":"C1502","DOI":"10.1152\/ajpcell.00346.2023","volume":"325","author":"MA Mohammad Nezhady","year":"2023","unstructured":"Mohammad Nezhady MA, Modaresinejad M, Zia A, Chemtob S. Versatile lactate signaling via HCAR1: a multifaceted GPCR involved in many biological processes. Am J Physiol Cell Physiol. 2023;325(6):C1502\u201315.","journal-title":"Am J Physiol Cell Physiol"},{"key":"2216_CR80","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2020-CT129","author":"D Papadatos-Pastos","year":"2022","unstructured":"Papadatos-Pastos D, Yuan W, Pal A, Crespo M, Ferreira A, Gurel B, et al. Phase 1, dose-escalation study of guadecitabine (SGI-110) in combination with pembrolizumab in patients with solid tumors. J Immunother Cancer. 2022. https:\/\/doi.org\/10.1158\/1538-7445.AM2020-CT129","journal-title":"J Immunother Cancer"},{"issue":"11","key":"2216_CR81","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1158\/1078-0432.CCR-22-3642","volume":"29","author":"HJ Jang","year":"2023","unstructured":"Jang HJ, Hostetter G, Macfarlane AW, Madaj Z, Ross EA, Hinoue T, et al. A Phase II Trial of Guadecitabine plus Atezolizumab in Metastatic Urothelial Carcinoma Progressing after Initial Immune Checkpoint Inhibitor Therapy. Clin cancer research: official J Am Association Cancer Res. 2023;29(11):2052\u201365.","journal-title":"Clin cancer research: official J Am Association Cancer Res"}],"container-title":["Clinical Epigenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13148-026-02216-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-026-02216-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13148-026-02216-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T05:02:49Z","timestamp":1792558969000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13148-026-02216-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,27]]},"references-count":81,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2216"],"URL":"https:\/\/doi.org\/10.1186\/s13148-026-02216-8","relation":{},"ISSN":["1868-7083"],"issn-type":[{"value":"1868-7083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,27]]},"assertion":[{"value":"5 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"191"}}